NABRIVA THERAPEUTICS

nabriva-therapeutics-logo

Nabriva Therapeutics is a biopharmaceutical company engaged in the commercialization and development of innovative anti-infective agents to treat serious infections. Nabriva Therapeutics received U.S. Food and Drug Administration approval for XENLETA® (lefamulin injection, lefamulin tablets), the first systemic pleuromutilin antibiotic for community-acquired bacterial pneumonia (CABP). Nabriva Therapeutics is also developing CONTEPO™ (fosfomycin) for injection, a potential first-in-class epox... ide antibiotic for complicated urinary tract infections (cUTI), including acute pyelonephritis. Nabriva entered into an exclusive agreement with subsidiaries of Merck & Co. Inc., Kenilworth, N.J., USA to market, sell and distribute SIVEXTRO® (tedizolid phosphate) in the United States and certain of its territories.

#SimilarOrganizations #People #Financial #Event #Website #More

NABRIVA THERAPEUTICS

Social Links:

Industry:
Biotechnology Health Care Medical

Founded:
2001-01-01

Address:
Vienna, Wien, Austria

Country:
Austria

Website Url:
http://www.nabriva.com

Total Employee:
101+

Status:
Active

Contact:
(430) 174-0930

Email Addresses:
[email protected]

Total Funding:
325.87 M USD

Technology used in webpage:
LetsEncrypt IPv6 New Relic Mobile Optimized FLoC Opt-Out FLoC Drupal Akamai Hosted Adobe Dynamic Tag Management LiveChat


Similar Organizations

affimed-logo

Affimed

Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.

edgewise-therapeutics-logo

Edgewise Therapeutics

Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.

piqur-therapeutics-logo

PIQUR Therapeutics

PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.

salix-pharmaceuticals-logo

Salix Pharmaceuticals

Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.


Current Advisors List

axel-bolte_image

Axel Bolte Member of the Board of Directors @ Nabriva Therapeutics
Board_member

charles-rowland_image

Charles Rowland Member of the Board of Directors @ Nabriva Therapeutics
Board_member
2015-01-01

anja-könig_image

Anja König Board Positions @ Nabriva Therapeutics
Board_member

david-chiswell_image

David Chiswell Chairman @ Nabriva Therapeutics
Board_member
2012-06-01

axel-bolte_image

Axel Bolte Member of the Board of Directors @ Nabriva Therapeutics
Board_member

Current Employees Featured

ted-schroeder_image

Ted Schroeder
Ted Schroeder CEO @ Nabriva Therapeutics
CEO
2018-07-01

denise-pollard-knight_image

Denise Pollard-Knight
Denise Pollard-Knight Director @ Nabriva Therapeutics
Director

not_available_image

Christine Guico-Pabia
Christine Guico-Pabia Chief Medical Officer @ Nabriva Therapeutics
Chief Medical Officer
2021-10-01

Founder


rodger-novak_image

Rodger Novak

Stock Details


Company's stock symbol is NASDAQ:NBRV

Acquisitions List

Date Company Article Price
2018-07-25 Zavante Therapeutics Zavante Therapeutics acquired by Nabriva Therapeutics N/A

Investors List

armentum-partners_image

Armentum Partners

Armentum Partners investment in Post-IPO Debt - Nabriva Therapeutics

herculescapital_image

Hercules Capital

Hercules Capital investment in Post-IPO Debt - Nabriva Therapeutics

novartis-venture-fund_image

Novartis Venture Fund

Novartis Venture Fund investment in Series B - Nabriva Therapeutics

gls-ventures_image

GLS Ventures

GLS Ventures investment in Series B - Nabriva Therapeutics

ecor1-capital_image

EcoR1 Capital

EcoR1 Capital investment in Series B - Nabriva Therapeutics

wellcome-trust_image

Wellcome Trust

Wellcome Trust investment in Series B - Nabriva Therapeutics

hbm-healthcare-investments-ag_image

HBM Healthcare Investments AG

HBM Healthcare Investments AG investment in Series B - Nabriva Therapeutics

orbimed-advisors_image

OrbiMed

OrbiMed investment in Series B - Nabriva Therapeutics

phase4-partners_image

Phase4 Partners

Phase4 Partners investment in Series B - Nabriva Therapeutics

vivo-capital_image

Vivo Capital

Vivo Capital investment in Series B - Nabriva Therapeutics

Official Site Inspections

http://www.nabriva.com Semrush global rank: 8.11 M Semrush visits lastest month: 365

  • Host name: 52.176.165.69
  • IP address: 52.176.165.69
  • Location: Des Moines United States
  • Latitude: 41.6006
  • Longitude: -93.6112
  • Metro Code: 679
  • Timezone: America/Chicago
  • Postal: 50307

Loading ...

More informations about "Nabriva Therapeutics" on Search Engine